Buy Hepcinat LP Tablets : Treatment of hepatitis C with Ledipasvir and Sofosbuvir
The antiviral medicines Hepcinat LP is recommended for used to treat adults with chronic (long-term) hepatitis C, an infectious disease that affects the liver caused by the hepatitis C virus. The duration of treatment with Hepcinat LP and whether it is used alone or in combination with another medicine called ribavirin depends on the genotype of the virus and the nature of the liver problems patients have, for example if they have liver cirrhosis (scarring) or their liver is not working properly.
Hepcinat LP contains the active substances Ledipasvir and Sofosbuvir.
Hepcinat LP can only be obtained with a prescription and treatment should be started and monitored by a doctor experienced in the management of patients with chronic hepatitis C.
Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer. The active substances in Hepcinat LP work together by blocking two different proteins that the virus needs to grow and reproduce itself. Sofosbuvir blocks the action of a protein called ‘NS5B RNA-dependent RNA polymerase’, while Ledipasvir targets a protein called ‘NS5A’. By blocking these proteins, Hepcinat LP stops the hepatitis C virus from multiplying and infecting new cells.
- In those cases, if the full course of treatment with the drug Hepcinat LP did not give a positive result, the patient needs to select an alternative agent for the treatment of chronic viral hepatitis C.
- This drug is not accompanied by negative effects on the ability to perform accurate work and drive.
- To avoid the development of unforeseen side effects, therapy with this antiviral agent is contraindicated for children, pregnant and lactating women.
- Hepcinat LP Tablets should be stored in a dark, dry place, away from children. Shelf life of the drug is 24 months.